Business Wire

IDEMIA Commits to Training French Young People and Will Triple the Number of Trainees In 2020

Share

IDEMIA, the global leader in Augmented Identity, today launched an ambitious and novel French training program. At a time when the current health, economic and social crisis is hitting young people really hard, the Group has taken a strategic long-term decision to step up training and pledges to triple the number of sandwich course trainees hiring 100 graduates by the year-end.

While Covid-19 has caused a global economic slump, IDEMIA pledges to raise the number of its sandwich course trainees to 150 by the end of 2020, with a view to making them a top talent pool for the Company’s latest-tech France-based jobs. In so doing, the Group reaffirms the importance it places on staff training in its innovation policy.

These new trainees will go to all the Company’s French locations including the Courbevoie corporate head office, the Osny, Pessac, Meyreuil and Sophia Antipolis R&D centers, the Vitré and Saint-Etienne-du-Rouvray manufacturing plants and the Dijon services center.

Hired trainees will work in jobs and businesses that each location is responsible for, including IT development, software, datascience and deep learning engineering and project management. Some will also work for support departments like HR, procurement, finance, communications and market intelligence. Most sandwich course hires will have had at least four years post-baccalaureate higher education experience and they will be offered 18 to 24 month trainee/employment contracts depending on each one’s experience.

IDEMIA’s move to ramp up its training programs forms part of its pledge to hire and support top quality staff from all backgrounds and ethnicities, especially in France the Group’s home country, which represents a huge source of sandwich course trainees. Indeed the Company sponsors several world class engineering schools.

IDEMIA’s VP Human Resources Jeremy Roffe-Vidal said: “At IDEMIA, we are immensely proud to be involved in training top quality people. Our ambitious goal in 2020 to hire 100 sandwich course trainees in France bears out the long-term view we take of our business. Given that we do business in various worldwide markets, we can offer both graduates and experienced professionals a broad array of job opportunities in engineering research, management and sales”.

About IDEMIA
IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.
Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.

With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.

For more information, visit www.idemia.com / Follow @IDEMIAGroup on Twitter

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contact:
Hanna Sebbah
idemia@havas.com
+33 (0) 6 63 73 30 30

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Crexendo and NUSO Partner to Deliver Global Cloud Communications Capabilities23.10.2025 16:15:00 EEST | Press release

NUSO, a leading provider of cloud communications service delivery, today announced it has been chosen by Crexendo®, Inc. (NASDAQ:CXDO), an award-winning software technology company that is a premier provider of cloud communication platform software and unified communication as a service (UCaaS) offerings, including voice, video, contact center, and managed IT services tailored to businesses of all sizes, to be a preferred carrier for the Crexendo cloud communications platform. The expanded partnership allows Crexendo platform licensees to offer cloud communications capabilities over NUSO’s global delivery network, unlocking new revenue opportunities for service providers. With NUSO’s carrier footprint in more than 40 countries, the Crexendo platform now offers global service delivery with industry-leading call quality, uptime, and emergency calling compliance. Platform providers can now offer global service delivery to over 6 million end users worldwide who rely on Crexendo’s Netsapien

SK pharmteco Boosts Domestic Peptide Scale-Up with Investment in California Facility23.10.2025 16:03:00 EEST | Press release

SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facility to expand and equip a new lab and CGMP-Kilo-scale facility for Solid-Phase Peptide Synthesis (SPPS) and purification. This expansion, combined with SK pharmteco’s industry-leading chromatography expertise and existing development and manufacturing capabilities in the United States, positions the company to meet the rising demand for U.S. peptide development and domestic clinical and commercial manufacturing. "The investment in our California facility represents a key milestone in our strategic growth and demonstrates an unwavering dedication to the domestic biopharma sector,” said Joerg Ahlgrimm, CEO of SK pharmteco. “Peptides are a vital and rapidly advancing therapeutic category. This project highlights our ongoing commitment to furthering their development and manufacturing.” “We are expanding our capacity to meet the increasing

Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK ® at the North American Cystic Fibrosis Conference23.10.2025 16:00:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s most recently approved medicine, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), at the North American Cystic Fibrosis Conference (NACFC) held from October 22-25 in Seattle, Washington. Several of the abstracts that will be presented at this year’s conference demonstrate that improvement in CFTR function, as measured by reduction in sweat chloride (SwCl), is associated with improved outcomes in people with cystic fibrosis (CF). ALYFTREK has shown greater reductions in sweat chloride compared to TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Phase 3 trials, suggesting that ALYFTREK has the potential for even greater improvements in quality of life and other health-related outcomes. Data being presented on ALYFTREK and on correlation between lower SwCl and improved clinical

Boomi Recognized as an Exemplary Vendor in the ISG Buyers Guides™ for Data Integration and Master Data Management 202523.10.2025 16:00:00 EEST | Press release

Boomi™, the leader in AI-driven automation, today announced it has been named an Exemplary Vendor in both the ISG Buyers Guide™ for Data Integration and the ISG Buyers Guide™ for Master Data Management 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023515342/en/ Boomi Recognized as an Exemplary Vendor in the ISG Buyers Guides™ for Data Integration and Master Data Management 2025 In these independently published reports from ISG Software Research, a division of ISG (Information Services Group), Boomi was recognized as a Leader across multiple evaluation dimensions, including Product Experience, Capability, Customer Experience, and Validation. Customer Experience and Validation The ISG Buyers Guide™ assessments are widely used by enterprise technology buyers to evaluate market-leading software solutions. Boomi’s placement in both guides reflects its commitment to delivering a unified, AI-ready platform that helps orga

CWAN and J.P. Morgan Asset Management Launch Automated Cash Management Solution for Hedge Funds23.10.2025 16:00:00 EEST | Press release

Clearwater Analytics (NYSE: CWAN), the most comprehensive technology platform for investment management, and J.P. Morgan Asset Management today announced an integration that transforms how hedge funds manage cash. The solution links Enfusion by CWAN directly with the Morgan Money® trading platform, J.P. Morgan Asset Management’s short-term investment management solution, giving clients a single, automated workflow for investing and monitoring idle cash. Through this connection, hedge funds can now: Maximize idle cash by automatically investing in a diversified range of money market funds. Reduce concentration risk by spreading cash across multiple managers, custodians, and currencies. Improve liquidity visibility through real-time data and automated withdrawal and deposit capabilities. Eliminate manual treasury work, freeing teams to focus on trading and strategy. “Every dollar sitting in a single account represents both a missed opportunity and unnecessary concentration risk,” said Sc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye